Lucid intends to use the proceeds "for general corporate purposes, which may include, among other things, capital expenditures and working capital." ...
SANUWAVE's end-to-end wound care portfolio of regenerative medicine products and product candidates helps restore the body’s normal healing processes. SANUWAVE applies and researches its patented ...